Evidence map›Paper›PMID 35163191›Full record

ArticleInternational journal of molecular sciences2022

Ahmad Aljohmani, Bastian Opitz, Markus Bischoff, Daniela Yildiz

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Exploring the Role ofACS infectious diseases · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Pore-forming activity ofInfection and immunity · 2023
    Article
  10. Cells · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ahmad AljohmaniInstitute of Experimental and Clinical Pharmacology and Toxicology, PZMS, ZHMB, Saarland University, 66421 Homburg, Germany.ORCID 0000-0003-0982-3583
Bastian OpitzDepartment of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Markus BischoffInstitute for Medical Microbiology and Hygiene, Saarland University, 66421 Homburg, Germany.
Daniela YildizInstitute of Experimental and Clinical Pharmacology and Toxicology, PZMS, ZHMB, Saarland University, 66421 Homburg, Germany.
Saarland University · DEHumboldt-Universität zu Berlin · DEInstitute of Medical Microbiology and Hygiene · DE

Funding

Deutsche Forschungsgemeinschaft DR1013/1-1HIPS-UdS TANDEM initiative Project 1
6 · The paper itself

Abstract

Pneumonia is a life-threatening disease often caused by infection with

Indexed as

ProteolysisA549 CellsADAM10 ProteinAmyloid Precursor Protein SecretasesAntigens, CDCadherinsEpitheliumExosomesHumansInflammationMembrane ProteinsPseudomonas aeruginosaTHP-1 CellsADAM10 ProteinADAM10 protein, humanAmyloid Precursor Protein SecretasesAntigens, CDCadherinsCDH1 protein, humanMembrane Proteinscell-cell-communicationexosomesinfectionmetalloproteinaseproteolysis

Identifiers

PMID35163191
PMCPMC8835980
OpenAlexW4207051100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.